Stay updated on PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has updated its version from v2.16.11 to v2.16.12 and has removed several previous dates while adding new ones for August 2025.SummaryDifference0.5%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
- Check35 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check43 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.6, replacing the previous version v2.16.5. The phrasing regarding the last update has also changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check50 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a service alert for planned maintenance affecting services in North Carolina, while information regarding California locations and UCLA Medical Center has been removed.SummaryDifference5%
Stay in the know with updates to PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06939926 Safety/Efficacy in Duchenne Muscular Dystrophy Clinical Trial page.